The market analysis of medicinal products and dietary supplements containing lactulose
Social Pharmacy in Health Care · 03.07.2026 · 12 (2) · 61-68
DOI: 10.24959/sphhcj.26.390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Social Pharmacy in Health Care, online erschienen am 03.07.2026. Verfasst von I. V. Vladymyrova und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gastrointestinal tract diseases, particularly functional disorders of the large intestine and deterioration of the gut microbiota, are widespread across various age groups of the population. To restore the physiological condition of the intestine in adults and children, lactulose, which is included in the list of recommended remedies for treating functional intestinal disorders, is used.
Aim
To analyze the pharmaceutical market of medicinal products and dietary supplements containing lactulose. Materials and methods. Desk-based methods of the system analysis and the content analysis, as well as the statistical method were used. The sources of information included data from the State Register of Medicines of Ukraine, the “Tabletki.ua” information resource, analytical reviews of the pharmaceutical market, and international scientific publications. Results and discussion. It was determined that the range of medicinal products containing lactulose was represented by 7 registered trade names belonging to the pharmacotherapeutic group “Osmotic laxatives. ATC code A06A D11” according to the ATC classification. The lactulose content was presented in doses of 670 mg/mL and 667 mg/mL. Syrups predominated among dosage forms, accounting for 85.70% of the total market for lactulose-containing medicines. The analysis of drug manufacturers by country of origin found the vast majority of domestic manufacturers (54.5 %), with the Netherlands (27.2 %) and Croatia (18.3 %) represented among other countries. The price liquidity coefficient indicators for medicinal products were analyzed; the maximum value of the price liquidity coefficient (0.18) was determined for “Normolact” syrup, 670 mg/mL, 200 mL in a bottle. The analysis of the market for dietary supplements containing lactulose showed similar trends by dosage form: 87.50 % of the products available in the market were in the form of syrup, while 12.50 % were in the form of sachet. The manufacturers of dietary supplements were domestic producers, such as PJSC “Pharmaceutical Factory Viola” (Zaporizhzhia) (75.0 %), LLC “Unatis” (Bucha, Kyiv Oblast) (12.5 %), LLC “NLP Fitoprodukt” (Kharkiv) (12.5 %). The calculated price liquidity ratio demonstrated a high economic accessibility of dietary supplements – within the range from 0.02 to 0.11.
Conclusions
The analysis of the pharmaceutical market of Ukraine has shown that the range of medicinal products and dietary supplements containing lactulose is characterized by a relatively limited number of brands and the dominance of liquid dosage forms. Domestically manufactured products have been found to dominate the market, particularly in the dietary supplement segment. Low price liquidity ratios (≤ 0.18) may indicate a well-established competitive environment in the segment of lactulose-containing products, which contributes to maintaining a moderate price level and indirectly characterizes the affordability for the population. The limited range of dosage forms available has been revealed. Taking into account the legislative changes taking place in the pharmaceutical market of Ukraine and defining clear limits on the potential applications and positioning of dietary supplements with lactulose, it can be also argued that expanding the product range is advisable, using modern approaches to improving compliance and ease of use, particularly in pediatric practice.
Zitieren
APA
Vladymyrova, I. V., & Lebedynets, V. O. (2026). The market analysis of medicinal products and dietary supplements containing lactulose. Social Pharmacy in Health Care, 12(2), 61-68. https://doi.org/10.24959/sphhcj.26.390
Vancouver
Vladymyrova IV, Lebedynets VO. The market analysis of medicinal products and dietary supplements containing lactulose. Social Pharmacy in Health Care. 2026;12(2):61-68. doi:10.24959/sphhcj.26.390
BibTeX
@article{Vladymyrova2026,
author = {Vladymyrova, I. V. and Lebedynets, V. O.},
title = {The market analysis of medicinal products and dietary supplements containing lactulose},
journal = {Social Pharmacy in Health Care},
year = {2026},
volume = {12},
number = {2},
pages = {61--68},
doi = {10.24959/sphhcj.26.390}
}
EUVIMED